Shift Bioscience

Investors · 3

F-

F-Prime CapitalCambridge · $3M – $10M

KI

Kindred CapitalLondon

$16M disclosed across 1 round · 2024

• $16MSeed fundingOct 2024 · 3 sources

  BGF (lead), F-Prime Capital, Kindred Capital

  Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

PR

Precision BioSciences9 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

LI

Life Biosciences8 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan

DR

Dropletbiosci8 shared keywordsDroplet Biosciences develops cancer diagnostics with a focus on liquid biopsy and precision oncology. The company works in the molecular diagnostics space for cancer detection and personalized medicine.

MA

Mammoth Biosciences7 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.

TR

Transition Bio7 shared keywordsTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.

TW

Twist Bioscience5 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

Companies competing with Shift Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Registered name

SHIFT BIOSCIENCE LIMITED

Company number

10793871

Status

Active

Company type

Private limited company

Incorporated

30 May 2017

Registered office

Salisbury House, Station Road, Cambridge, CB1 2LA

Nature of business (SIC)

72110 — Research and experimental development on biotechnology

Previous names

NEXTNEURAL LIMITED (2017–2017)

Accounts

last made up to 30 Jun 2025 · next due 31 Mar 2027

Confirmation statement

last made up to 13 Apr 2026 · next due 27 Apr 2027

Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.